On the public citation graph
Synthesis of some novel potent and selective catechol O-methyltransferase inhibitors
0 signed · 137 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/(sici)1098-2299(199709)42:1<1::aid-ddr1>3.0.co;2-iopenalex-snapshot
Catechol-O-methyltransferase inhibitors: Clinical potential in the treatment of Parkinson's disease
inferred← citeshttps://doi.org/10.1002/(sici)1098-2396(199805)29:1<37::aid-syn4>3.0.co;2-copenalex-snapshot
Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms
inferred← citeshttps://doi.org/10.1002/(sici)1098-2396(199812)30:4<351::aid-syn2>3.0.co;2-2openalex-snapshot
Effect of catechol-O-methyltransferase inhibition on brain uptake of [18F]fluorodopa: Implications for compartmental modelling and clinical usefulness
inferred← citeshttps://doi.org/10.1002/1098-2299(200004)49:4<238::aid-ddr2>3.0.co;2-vopenalex-snapshot
Effects of aqueous solubility and dissolution characteristics on oral bioavailability of entacapone
inferred← citeshttps://doi.org/10.1002/1098-2396(200104)40:1<19::aid-syn1022>3.0.co;2-7openalex-snapshot
Detection of response to COMT inhibition in FDOPA PET in advanced Parkinson's disease requires prolonged imaging
inferred← citeshttps://doi.org/10.1002/9780470682531.pat0134openalex-snapshot
Syntheses and Uses of Isotopically Labelled Compounds Containing C C , C O or C N Groups
inferred← citeshttps://doi.org/10.1002/9780470921920.edm027openalex-snapshot
Mechanisms of Drug Metabolism
inferred← citeshttps://doi.org/10.1002/9783527808694.ch11openalex-snapshot
Opicapone, a Novel Catechol‐O‐Methyltranferase Inhibitor ( COMT ) to Manage the Symptoms of P arkinson's Disease
inferred← citeshttps://doi.org/10.1002/adsc.201601025openalex-snapshot
Titanium(IV) Chloride‐Mediated Stereoselective α‐Alkylidenation to Efficiently Assemble Multisubstituted 1,3‐Dienes
inferred← citeshttps://doi.org/10.1002/hlca.19890720511openalex-snapshot
Catechol‐O‐methyltransferase‐Inhibiting Pyrocatechol Derivatives: Synthesis and Structure‐Activity Studies
inferred← citeshttps://doi.org/10.1002/jlcr.2580290214openalex-snapshot
Synthesis of two 14C‐labelled catechol‐O‐methyltransferase inhibitors
inferred← citeshttps://doi.org/10.1002/mds.870080308openalex-snapshot
Administration of the new COMT inhibitor OR‐611 increases striatal uptake of fluorodopa
inferred← citeshttps://doi.org/10.1002/prot.340110309openalex-snapshot
Crystallization and preliminary X‐ray investigation of a recombinant form of rat catechol O‐methyltransferase
inferred← citeshttps://doi.org/10.1002/qsar.19890080304openalex-snapshot
QSAR and Binding Model for Inhibition of Rat Liver Catechol‐O‐Methyl‐Transferase by 1,5‐Substituted‐3,4‐Dihydroxybenzenes
inferred← citeshttps://doi.org/10.1002/qsar.200730053openalex-snapshot
A 3‐D QSAR Study of Catechol‐O‐Methyltransferase Inhibitors Using CoMFA and CoMSIA
inferred← citeshttps://doi.org/10.1007/1-4020-2291-3_1openalex-snapshot
Compounds derived from acetic acid
inferred← citeshttps://doi.org/10.1007/978-1-4020-9787-4_24openalex-snapshot
Aromatic Ketones Containing One Isobutyryl Group
inferred← citeshttps://doi.org/10.1007/978-1-4020-9787-4_9openalex-snapshot
Compounds Derived from Acetic Acid
inferred← citeshttps://doi.org/10.1007/978-3-0348-7144-0_9openalex-snapshot
Characteristics of catechol O-methyltransferase (COMT) and properties of selective COMT inhibitors
inferred← citeshttps://doi.org/10.1007/978-3-642-78429-3_7openalex-snapshot
O-, N- and S-Methyltransferases
inferred← citeshttps://doi.org/10.1007/bf00123380openalex-snapshot
PLS modelling of structure?activity relationships of catechol O-methyltransferase inhibitors
inferred← citeshttps://doi.org/10.1007/bf00172580openalex-snapshot
Effect of high single doses of levodopa and carbidopa on brain dopamine and its metabolites: modulation by selective inhibitors of monoamine oxidase and/or catechol-O-methyltransferase in the male rat
inferred← citeshttps://doi.org/10.1007/bf00173538openalex-snapshot
Biochemical and pharmacological properties of a peripherally acting catechol-O-methyltransferase inhibitor entacapone
inferred← citeshttps://doi.org/10.1007/bf00199880openalex-snapshot
Inhibition of soluble catechol-O-methyltransferase and single-dose pharmacokinetics after oral and intravenous administration of entacapone
inferred← citeshttps://doi.org/10.1007/bf00271374openalex-snapshot
The effects of the COMT inhibitor nitecapone for one week on exercise haemodynamics and catecholamine disposition
inferred← citeshttps://doi.org/10.1007/bf00315512openalex-snapshot
Effect of entacapone, a COMT inhibitor, on the pharmacokinetics of levodopa and on cardiovascular responses in patients with Parkinson's disease
inferred← citeshttps://doi.org/10.1007/bf01271232openalex-snapshot
COMT inhibition by entacapone does not affect growth hormone or prolactin secretion in healthy volunteers
inferred← citeshttps://doi.org/10.1007/bf03188833openalex-snapshot
Metabolite profiles of two [14C]-labelled catechol O-methyltransferase inhibitors, nitecapone and entacapone, in rat and mouse urine and rat bile
inferred← citeshttps://doi.org/10.1007/bf03190186openalex-snapshot
Identification of major urinary metabolites of the catechol-O-methyltransferase inhibitor entacapone in the dog
inferred← citeshttps://doi.org/10.1007/pl00007743openalex-snapshot
COMT inhibition in the treatment of Parkinson’s disease
inferred← citeshttps://doi.org/10.1007/s002280050197openalex-snapshot
Simultaneous inhibition of catecholamine- O -methylation by entacapone and neuronal uptake by imipramine: lack of interactions
inferred← citeshttps://doi.org/10.1007/s007020050123openalex-snapshot
PET studies of peripheral catechol-O-methyltransferase in non-human primates using [ 18 F]Ro41-0960
inferred← citeshttps://doi.org/10.1007/s11095-007-9255-yopenalex-snapshot
Novel L-Dopa and Dopamine Prodrugs Containing a 2-Phenyl-imidazopyridine Moiety
inferred← citeshttps://doi.org/10.1016/0003-2697(92)90501-wopenalex-snapshot
The use of a spectrophotometric assay to study the interaction of S-adenosylmethionine synthetase with methionine analogues
inferred← citeshttps://doi.org/10.1016/0006-2952(89)90673-4openalex-snapshot
Inhibition of rat liver and duodenum soluble catechol-O-methyltransferase by a tight-binding inhibitor OR-462
inferred← citeshttps://doi.org/10.1016/0006-2952(93)90006-iopenalex-snapshot
Inhibition of catechol-O-methyltransferase by 1-vinyl derivatives of nitrocatechols and nitroguaiacols
inferred← citeshttps://doi.org/10.1016/0006-2952(95)00243-xopenalex-snapshot
Induction of cytotoxicity in melanoma cells through inhibition of catechol-O-methyltransferase
inferred← citeshttps://doi.org/10.1016/0006-8993(92)91003-wopenalex-snapshot
Effects of COMT inhibitors on striatal dopamine metabolism: a microdialysis study
inferred← citeshttps://doi.org/10.1016/0006-8993(93)90556-3openalex-snapshot
6-[18F]Fluoro-l-dihydroxyphenylalanine metabolism and positron emission tomography aftercatechol-O-methyltransferase inhibition in normal and hemiparkinsonian monkeys
inferred← citeshttps://doi.org/10.1016/0009-9236(95)90200-7openalex-snapshot
The effect of entacapone on the disposition and hemodynamic effects of intravenous isoproterenol and epinephrine*
inferred← citeshttps://doi.org/10.1016/0014-2999(94)90693-9openalex-snapshot
Effect of catechol-O-methyl transferase inhibition on peripheral and central metabolism of 6-[18F]fluoro-L-DOPA
inferred← citeshttps://doi.org/10.1016/0024-3205(95)02277-5openalex-snapshot
Mapping Catechol-O-Methyltransferase in vivo: Initial studies with [18F]RO41-0960
inferred← citeshttps://doi.org/10.1016/0076-6879(94)34125-7openalex-snapshot
[54] Antioxidant activity of nitecapone and its analog OR-1246: Effect of structural modification on antioxidant action
inferred← citeshttps://doi.org/10.1016/0306-3623(94)90082-5openalex-snapshot
General properties and clinical possibilities of new selective inhibitors of catechol O-methyltransferase
inferred← citeshttps://doi.org/10.1016/0731-7085(91)80238-5openalex-snapshot
Determination of a catechol-O-methyltransferase inhibitor, nitecapone, in human plasma and urine by liquid chromatography
inferred← citeshttps://doi.org/10.1016/0731-7085(95)01645-7openalex-snapshot
Validation of assay of catechol-O-methyltransferase activity in human erythrocytes
inferred← citeshttps://doi.org/10.1016/0959-440x(94)90268-2openalex-snapshot
Structure-based drug design
inferred← citeshttps://doi.org/10.1016/b978-0-12-381326-8.00005-3openalex-snapshot
Biochemistry and Pharmacology of Catechol-O-Methyltransferase Inhibitors
inferred← citeshttps://doi.org/10.1016/b978-0-12-381326-8.00006-5openalex-snapshot
The Chemistry of Catechol-O-Methyltransferase Inhibitors
inferred← citeshttps://doi.org/10.1016/b978-0-12-381326-8.00007-7openalex-snapshot
Toxicology and Safety of Comt Inhibitors
inferred← citeshttps://doi.org/10.1016/b978-0-12-823974-2.00029-2openalex-snapshot
Catechol-O-methyltransferase (COMT)
inferred← citeshttps://doi.org/10.1016/b978-0-444-81369-5.50017-1openalex-snapshot
Catechol-O-methyltransferase
inferred← citeshttps://doi.org/10.1016/bs.irn.2017.01.006openalex-snapshot
Hallmarks of Treatment Aspects: Parkinson's Disease Throughout Centuries Including l -Dopa
inferred← citeshttps://doi.org/10.1016/j.ab.2004.04.026openalex-snapshot
Microplate screening assay to identify inhibitors of human catechol-O-methyltransferase
inferred← citeshttps://doi.org/10.1016/j.ab.2007.09.025openalex-snapshot
A universal competitive fluorescence polarization activity assay for S-adenosylmethionine utilizing methyltransferases
inferred← citeshttps://doi.org/10.1016/j.bioorg.2019.103418openalex-snapshot
Neurological and psychiatric management using COMT inhibitors: A review
inferred← citeshttps://doi.org/10.1016/j.bjp.2015.07.002openalex-snapshot
The catechol-O-methyltransferase inhibitory potential of Z-vallesiachotamine by in silico and in vitro approaches
inferred← citeshttps://doi.org/10.1016/j.bmc.2007.02.054openalex-snapshot
Regulatory molecules for the 5-HT3 receptor ion channel gating system
inferred← citeshttps://doi.org/10.1016/j.drudis.2020.07.015openalex-snapshot
Liver says no: the ongoing search for safe catechol O-methyltransferase inhibitors to replace tolcapone
inferred← citeshttps://doi.org/10.1016/j.ejpain.2010.12.001openalex-snapshot
Nitecapone reduces development and symptoms of neuropathic pain after spinal nerve ligation in rats1
inferred← citeshttps://doi.org/10.1016/j.ejps.2005.04.002openalex-snapshot
A modification of the Hammett equation for predicting ionisation constants of p-vinyl phenols
inferred← citeshttps://doi.org/10.1016/j.fochx.2026.104183openalex-snapshot
Accurate quantification and antioxidant evaluation of avenanthramides in oat products using authentic reference standards
inferred← citeshttps://doi.org/10.1016/j.freeradbiomed.2007.08.005openalex-snapshot
Inhibition of catechol-O-methyltransferase increases estrogen–DNA adduct formation
inferred← citeshttps://doi.org/10.1016/j.freeradbiomed.2016.03.026openalex-snapshot
Synthesis, evaluation, and metabolism of novel [6]-shogaol derivatives as potent Nrf2 activators
inferred← citeshttps://doi.org/10.1016/j.jmgm.2012.10.010openalex-snapshot
Pharmacophore modeling and virtual screening studies to design potential COMT inhibitors as new leads
inferred← citeshttps://doi.org/10.1016/j.jneuroim.2014.09.004openalex-snapshot
The blood–brain barrier-permeable catechol-O-methyltransferase inhibitor dinitrocatechol suppresses experimental autoimmune encephalomyelitis
inferred← citeshttps://doi.org/10.1016/j.jpba.2010.05.003openalex-snapshot
Simultaneous determination of l-dopa and its prodrug (S)-4-(2-acetamido-3-ethoxy-3-oxopropyl)-1,2-phenylene diacetate in rat plasma by high-performance liquid chromatography–tandem mass spectrometry and its application in a pharmacokinetic study
inferred← citeshttps://doi.org/10.1016/j.neuropharm.2020.108353openalex-snapshot
Improved functional and histochemical outcomes in l-DOPA plus tolcapone treated VMAT2-deficient mice
inferred← citeshttps://doi.org/10.1016/s0006-8993(97)00552-0openalex-snapshot
Cerebral 6-[18F]fluoro-l-DOPA uptake in rhesus monkey: pharmacological influence of aromatic amino acid decarboxylase (AAAD) and catechol-O-methyltransferase (COMT) inhibition
inferred← citeshttps://doi.org/10.1016/s0009-9236(96)90115-0openalex-snapshot
Simultaneous inhibition of catechol-O-methyltransferase and monoamine oxidase A: Effects on hemodynamics and catecholamine metabolism in healthy volunteers*
inferred← citeshttps://doi.org/10.1016/s0014-2999(02)02383-xopenalex-snapshot
Effects of entacapone and tolcapone on mitochondrial membrane potential
inferred← citeshttps://doi.org/10.1016/s0014-2999(97)01157-6openalex-snapshot
Effects of monoamine oxidase and catechol-O-methyltransferase inhibition on dopamine turnover: A PET study with 6-[]l-DOPA
inferred← citeshttps://doi.org/10.1016/s0021-5198(19)39752-5openalex-snapshot
Molecular Orbital Studies on the Structure-Activity Relationships of Catechol O-Methyltransferase Inhibitors
inferred← citeshttps://doi.org/10.1016/s0021-9673(97)00885-6openalex-snapshot
Analysis of catechol-type glucuronides in urine samples by liquid chromatography–electrospray ionization-tandem mass spectrometry
inferred← citeshttps://doi.org/10.1016/s0022-2860(00)00859-0openalex-snapshot
Structural studies of acyl esters of entacapone
inferred← citeshttps://doi.org/10.1016/s0031-6997(24)01423-6openalex-snapshot
Catechol-O-methyltransferase (COMT): Biochemistry, Molecular Biology, Pharmacology, and Clinical Efficacy of the New Selective COMT Inhibitors
inferred← citeshttps://doi.org/10.1016/s0163-7258(98)00032-1openalex-snapshot
New, Selective Catechol-O-Methyltransferase Inhibitors as Therapeutic Agents in Parkinson’s Disease
inferred← citeshttps://doi.org/10.1016/s0166-4328(96)02242-5openalex-snapshot
Effects of selective catechol-O-methyltransferase inhibitors on single-trial passive avoidance retention in male rats
inferred← citeshttps://doi.org/10.1016/s0960-894x(00)00384-xopenalex-snapshot
Synthesis of a water-soluble prodrug of entacapone
inferred← citeshttps://doi.org/10.1016/s0968-0896(03)00061-0openalex-snapshot
Syntheses of Novel Diphenyl Piperazine Derivatives and Their Activities as Inhibitors of Dopamine Uptake in the Central Nervous System
inferred← citeshttps://doi.org/10.1016/s1044-0305(99)00021-5openalex-snapshot
Mass spectrometric and tandem mass spectrometric behavior of nitrocatechol glucuronides: A comparison of atmospheric pressure chemical ionization and electrospray ionization
inferred← citeshttps://doi.org/10.1021/acs.chemrev.3c00479openalex-snapshot
Parkinson’s Disease: Advances in Treatment and the Syntheses of Various Classes of Pharmaceutical Drug Substances
inferred← citeshttps://doi.org/10.1021/acs.chemrev.8b00201openalex-snapshot
Targeting Metalloenzymes for Therapeutic Intervention
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.6b00666openalex-snapshot
Development of Blood–Brain Barrier Permeable Nitrocatechol-Based CatecholO-Methyltransferase Inhibitors with Reduced Potential for Hepatotoxicity
inferred← citeshttps://doi.org/10.1021/acs.jpcb.1c10278openalex-snapshot
Prediction of COMT Inhibitors Using Machine Learning and Molecular Dynamics Methods
inferred← citeshttps://doi.org/10.1021/acschembio.5b00812openalex-snapshot
SAM/SAH Analogs as Versatile Tools for SAM-Dependent Methyltransferases
inferred← citeshttps://doi.org/10.1021/jm010980dopenalex-snapshot
Design and Synthesis of a Novel L-Dopa−Entacapone Codrug
inferred← citeshttps://doi.org/10.1021/jm0109964openalex-snapshot
Synthesis of 1-(3,4-Dihydroxy-5-nitrophenyl)-2-phenyl-ethanone and Derivatives as Potent and Long-Acting Peripheral Inhibitors of Catechol-O-methyltransferase
inferred← citeshttps://doi.org/10.1021/jm040848oopenalex-snapshot
Synthesis, Biological Evaluation, and Molecular Modeling Studies of a Novel, Peripherally Selective Inhibitor of Catechol-O-methyltransferase
inferred← citeshttps://doi.org/10.1021/jm0580454openalex-snapshot
Synthesis and Biological Evaluation of a Novel Series of “Ortho-Nitrated” Inhibitors of Catechol- O -methyltransferase
inferred← citeshttps://doi.org/10.1021/jm1001524openalex-snapshot
Discovery of a Long-Acting, Peripherally Selective Inhibitor of Catechol-O-methyltransferase
inferred← citeshttps://doi.org/10.1021/jm500572bopenalex-snapshot
Medicinal Chemistry of CatecholO-Methyltransferase (COMT) Inhibitors and Their Therapeutic Utility
inferred← citeshttps://doi.org/10.1021/jm9605187openalex-snapshot
Synthesis andin VitroEvaluation of Two Progressive Series of Bifunctional Polyhydroxybenzamide Catechol-O-methyltransferase Inhibitors
inferred← citeshttps://doi.org/10.1021/js960458sopenalex-snapshot
Iron(III)-Chelating Properties of the Novel Catechol O-Methyltransferase Inhibitor Entacapone in Aqueous Solution
inferred← citeshttps://doi.org/10.1023/a:1007965026738openalex-snapshot
A semiempirical study on inhibition of catechol O-methyltransferase by substituted catechols
inferred← citeshttps://doi.org/10.1038/368354a0openalex-snapshot
Crystal structure of catechol O-methyltransferase
inferred← citeshttps://doi.org/10.1038/sj.bjp.0702474openalex-snapshot
In vivo effects of new inhibitors of catechol‐O‐methyl transferase
inferred← citeshttps://doi.org/10.1038/sj.bjp.0702831openalex-snapshot
Catechol‐O‐methyltransferase activity in CHO cells expressing norepinephrine transporter
inferred← citeshttps://doi.org/10.1039/9781849737357-00083openalex-snapshot
Catechol‐O‐Methyl‐Transferase Inhibitors: Present Problems and Relevance of the New Ones
inferred← citeshttps://doi.org/10.1039/c5md00018aopenalex-snapshot
Exploring cinnamic acid scaffold: development of promising neuroprotective lipophilic antioxidants
inferred← citeshttps://doi.org/10.1080/00397910701821077openalex-snapshot
Convenient Synthesis of Tolcapone, a Selective Catechol‐O‐methyltransferase Inhibitor
inferred← citeshttps://doi.org/10.1080/00397910802219148openalex-snapshot
Synthesis of 7-Substituted-(2,3-dihydro-1,4-benzodioxin-5-yl)-piperazine
inferred← citeshttps://doi.org/10.1080/00397911.2010.539894openalex-snapshot
Efficient Approach to Pure Entacapone and Related Compounds
inferred← citeshttps://doi.org/10.1080/00397919708004075openalex-snapshot
Synthesis of 3-Aminopyrocatechol via Lithiated Intermediates
inferred← citeshttps://doi.org/10.1080/10406638.2022.2040546openalex-snapshot
Non-Infringing Efficient One-Pot Process for the Preparation of Pure Entacapone
inferred← citeshttps://doi.org/10.1080/10406639408031191openalex-snapshot
Catechol-O-methyltransferase: Factors Relating to the Carcinogenic Potential of Catecholestrogens
inferred← citeshttps://doi.org/10.1093/toxsci/kfh216openalex-snapshot
Phytochemicals Inhibit Catechol-O-Methyltransferase Activity in Cytosolic Fractions from Healthy Human Mammary Tissues: Implications for Catechol Estrogen-Induced DNA Damage
inferred← citeshttps://doi.org/10.1097/00004647-199609000-00010openalex-snapshot
Fluorodopa Positron Emission Tomography with an Inhibitor of Catechol- O -Methyltransferase: Effect of the Plasma 3- O -Methyldopa Fraction on Data Analysis
inferred← citeshttps://doi.org/10.1107/s1600536809035132openalex-snapshot
(E)-Ethyl 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylate
inferred← citeshttps://doi.org/10.1111/bcp.12169openalex-snapshot
Structure-based drug design of catechol-O-methyltransferase inhibitors for CNS disorders
inferred← citeshttps://doi.org/10.1111/j.1365-2125.1993.tb00394.xopenalex-snapshot
The effects of the COMT inhibitor entacapone on haemodynamics and peripheral catecholamine metabolism during exercise
inferred← citeshttps://doi.org/10.1111/j.1471-4159.1993.tb05831.xopenalex-snapshot
Effects of Catechol‐O‐Methyltransferase Inhibitors and L‐3,4‐Dihydroxyphenylalanine With or Without Carbidopa on Extracellular Dopamine in Rat Striatum
inferred← citeshttps://doi.org/10.1111/j.1476-5381.1994.tb13021.xopenalex-snapshot
Comparison of two new inhibitors of catechol O‐methylation on striatal dopamine metabolism: a microdialysis study in rats
inferred← citeshttps://doi.org/10.1111/j.1476-5381.2010.00999.xopenalex-snapshot
Inhibitors of catechol‐O‐methyltransferase sensitize mice to pain
inferred← citeshttps://doi.org/10.1111/j.1527-3458.2007.00020.xopenalex-snapshot
Catechol‐ O ‐methyltransferase and Its Inhibitors in Parkinson's Disease
inferred← citeshttps://doi.org/10.1111/j.1600-0773.1990.tb00756.xopenalex-snapshot
Rationale for Selective COMT Inhibitors as Adjuncts in the Drug Treatment of Parkinson's Disease
inferred← citeshttps://doi.org/10.1111/j.1600-0773.1991.tb00412.xopenalex-snapshot
Acute Toxicity of Three New Selective COMT Inhibitors in Mice with Special Emphasis on Interactions with Drugs Increasing Catecholaminergic Neurotransmission
inferred← citeshttps://doi.org/10.1111/j.1600-0773.1996.tb00224.xopenalex-snapshot
Minor Effect of Tolcapone, a Catechol‐ O‐Methyltransferase Inhibitor, on Extracellular Dopamine Levels Modified by Amphetamine or Pargyline: A Microdialysis Study in Anaesthetized Rats
inferred← citeshttps://doi.org/10.1124/dmd.106.010447openalex-snapshot
Human Metabolism of Nebicapone (BIA 3-202), a Novel Catechol-O-Methyltransferase Inhibitor: Characterization of in Vitro Glucuronidation
inferred← citeshttps://doi.org/10.1124/dmd.31.3.250openalex-snapshot
Molecular Modeling and Metabolic Studies of The Interaction of Catechol-O-Methyltransferase and a New Nitrocatechol Inhibitor
inferred← citeshttps://doi.org/10.1124/mol.106.023119openalex-snapshot
Comparative Study of ortho- and meta-Nitrated Inhibitors of Catechol-O-methyltransferase: Interactions with the Active Site and Regioselectivity of O-Methylation
inferred← citeshttps://doi.org/10.1136/jnnp.57.2.186openalex-snapshot
Effect of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, on the motor response to acute treatment with levodopa in patients with Parkinson's disease.
inferred← citeshttps://doi.org/10.1211/0022357011778025openalex-snapshot
Synthesis and in-vitro/in-vivo evaluation of orally administered entacapone prodrugs
inferred← citeshttps://doi.org/10.1517/13543784.8.4.453openalex-snapshot
Entacapone, a catechol-O-methyltransferase inhibitor for treating Parkinson’s disease: review and current status
inferred← citeshttps://doi.org/10.2165/00023210-199401030-00002openalex-snapshot
Clinical Potential of Catechol-O-Methyltransferase (COMT) Inhibitors as Adjuvants in Parkinsonʼs Disease
inferred← citeshttps://doi.org/10.2165/00023210-200721070-00002openalex-snapshot
Treatment of Cognitive Deficits Associated with Schizophrenia
inferred← citeshttps://doi.org/10.2174/1871524913666140109113341openalex-snapshot
Inhibitors of Catechol-O-methyltransferase in the Treatment of Neurological Disorders
inferred← citeshttps://doi.org/10.2174/187152712800672436openalex-snapshot
Role of Catechol-O-Methyltransferase (COMT)-Dependent Processes in Parkinson’s Disease and L-DOPA Treatment
inferred← citeshttps://doi.org/10.3109/14756369409020195openalex-snapshot
Kinetics of the Reversible Tight-Binding Inhibition of Pig Liver Catechol-O-Methyltransferase by [2-(3,4-Dihydroxy-2-Nitrophenyl) Vinyl] Phenyl Ketone
inferred← citeshttps://doi.org/10.3390/ph15010051openalex-snapshot
Discovery of Small Molecules as Membrane-Bound Catechol-O-methyltransferase Inhibitors with Interest in Parkinson’s Disease: Pharmacophore Modeling, Molecular Docking and In Vitro Experimental Validation Studies
inferred← citeshttps://doi.org/10.34626/45cb-0p93openalex-snapshot
Desenvolvimento de Novos Antioxidantes Lipofílicos como Solução Terapêutica para Doenças Neurodegenerativas
inferred← citeshttps://doi.org/10.34626/wryn-4b60openalex-snapshot
Opicapone Sulfation: Sulfotransferase Isoforms Characterization
inferred← citeshttps://doi.org/10.7249/rhq-06-01-05openalex-snapshot
Treatment for Dementia: Learning from Breakthroughs for Other Conditions
inferred← citeshttps://doi.org/10.7324/japs.2020.1010015openalex-snapshot
A comprehensive review on management of Parkinson's disease, inclusive of drug discovery and pharmacological approaches
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.